Gilead Sciences Inc buy melinda
Start price
31.08.17
/
50%
€74.64
Target price
27.12.17
€81.18
Performance (%)
-10.85%
End price
27.12.17
€65.60
Summary
This prediction ended on 27.12.17 with a price of €65.60. The prediction for Gilead Sciences Inc disappointed with a performance of -10.85%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Gilead Sciences Inc | -3.378% | -3.378% | -15.994% | 11.801% |
| iShares Core DAX® | 0.192% | 3.121% | 16.828% | 19.649% |
| iShares Nasdaq 100 | 1.245% | 5.051% | 31.022% | 56.928% |
| iShares Nikkei 225® | -0.992% | 1.101% | 9.804% | 6.691% |
| iShares S&P 500 | 0.154% | 2.864% | 26.511% | 47.657% |
Comments by melinda for this prediction
In the thread Gilead Sciences Inc diskutieren
genehmigt
Stribild
NDA # 203100 Cobicistat; Elvitegravir; Emtricitabin; Tenofovir Disoproxil Fumarat Tabletten; Oral-EXTRA 30 Gilead Sciences Inc Labeling Approved
(Vom Mitglied beendet)
Stopped prediction by melinda for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.80
19.04.20
19.04.20
€80.00
04.11.21
04.11.21
-26.85%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€67.97
27.03.18
27.03.18
€80.10
27.09.18
27.09.18
3.73%
27.09.18
27.09.18
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.42
05.03.18
05.03.18
€79.38
19.03.18
19.03.18
2.32%
19.03.18
19.03.18
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.45
10.05.16
10.05.16
€84.79
10.11.16
10.11.16
-8.50%
10.11.16
10.11.16
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€12.69
21.07.10
21.07.10
€22.50
22.12.10
22.12.10
9.55%
22.12.10
22.12.10